Literature DB >> 17497460

Furosemide prevents apoptosis and associated gene expression in a rat model of surgical ischemic acute renal failure.

Natarajan Aravindan1, Sheeja Aravindan, Bernhard J Riedel, Han-Rong Weng, Andrew D Shaw.   

Abstract

Recently, we demonstrated that furosemide improves renal hemodynamics and attenuates ischemia/reperfusion (I/R)-associated changes in angiogenesis-related gene expression. However, the effect of furosemide on I/R-induced apoptosis is not known. We utilized a rat model of acute ischemic nephropathy to test the hypothesis that furosemide attenuates I/R-induced apoptosis. Male Sprague-Dawley rats anesthetized with urethane (50 mg/kg) were randomly allocated into four groups (n = 6 each): sham operated saline infusion, sham operated with furosemide (30 microg/kg/hr) infusion, unilateral renal ischemia (1 hr) followed by six hours of reperfusion, and I/R with furosemide infusion. Apoptosis was measured in kidney samples and compared between groups using ANOVA with Bonferroni correction. Apoptosis-related gene expression was assessed using microarray analysis and validated with RT-PCR. Phosphorylation of Akt was analyzed using ELISA, and data were compared between groups using the Mann Whitney U test. Compared to the control group, I/R significantly (p < 0.001) induced apoptosis in both the cortex and medulla. Similarly, microarray analysis revealed that I/R induced (< or = two-fold increase compared to control group) 73 apoptosis-related genes. Phosphorylation of Akt was significantly (p < 0.05) downregulated after I/R. Treatment with furosemide significantly (p < 0.001) reduced I/R-induced apoptosis in both the cortex and medulla and attenuated the expression of 72 I/R-induced apoptosis-related genes. Compared to the I/R group, furosemide significantly (p < 0.01) upregulated the phosphorylation of Akt. These data suggest that a low dose furosemide infusion may attenuate I/R-induced apoptosis and associated gene transcription, and imply a possible novel molecular basis for the mechanism of action of furosemide in acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497460     DOI: 10.1080/08860220701263671

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  10 in total

1.  Abscopal effect of low-LET γ-radiation mediated through Rel protein signal transduction in a mouse model of nontargeted radiation response.

Authors:  S Aravindan; M Natarajan; S K Ramraj; V Pandian; F H Khan; T S Herman; N Aravindan
Journal:  Cancer Gene Ther       Date:  2013-12-20       Impact factor: 5.987

Review 2.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Authors:  Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2017-05-04       Impact factor: 6.925

3.  The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.

Authors:  Sean M Bagshaw; R T Noel Gibney; Finlay A McAlister; Rinaldo Bellomo
Journal:  Trials       Date:  2010-05-11       Impact factor: 2.279

4.  Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer.

Authors:  Sheeja Aravindan; Satish Kumar Ramraj; Somasundaram T Somasundaram; Natarajan Aravindan
Journal:  J Biomed Sci       Date:  2015-04-17       Impact factor: 8.410

5.  Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.

Authors:  Sheeja Aravindan; Satishkumar Ramraj; Kathiresan Kandasamy; Somasundaram S Thirugnanasambandan; Dinesh Babu Somasundaram; Terence S Herman; Natarajan Aravindan
Journal:  Oncotarget       Date:  2017-01-24

6.  Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials.

Authors:  Tiziana Bove; Alessandro Belletti; Alessandro Putzu; Simone Pappacena; Giuseppe Denaro; Giovanni Landoni; Sean M Bagshaw; Alberto Zangrillo
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

7.  Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial.

Authors:  Heyman Luckraz; Ramesh Giri; Benjamin Wrigley; Kumaresan Nagarajan; Eshan Senanayake; Emma Sharman; Lawrence Beare; Alan Nevill
Journal:  Eur J Cardiothorac Surg       Date:  2021-04-13       Impact factor: 4.191

8.  Fluid balance and urine volume are independent predictors of mortality in acute kidney injury.

Authors:  Catarina Teixeira; Francesco Garzotto; Pasquale Piccinni; Nicola Brienza; Michele Iannuzzi; Silvia Gramaticopolo; Francesco Forfori; Paolo Pelaia; Monica Rocco; Claudio Ronco; Clara Belluomo Anello; Tiziana Bove; Mauro Carlini; Vincenzo Michetti; Dinna N Cruz
Journal:  Crit Care       Date:  2013-01-24       Impact factor: 9.097

9.  Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial.

Authors:  Shilpa Abraham; Ramachandran Rameshkumar; Muthu Chidambaram; Rajendran Soundravally; Seenivasan Subramani; Rohit Bhowmick; Abraar Sheriff; Kaushik Maulik; Subramanian Mahadevan
Journal:  Indian J Pediatr       Date:  2021-04-02       Impact factor: 1.967

10.  Clinical significance of frusemide stress test in predicting the severity of acute kidney injury.

Authors:  Arun Gokul Pon; Raveendran Vairakkani; Edwin Fernando Mervin; Nagalakshmi Dhanapal Srinivasaprasad; Thirumalvalavan Kaliaperumal
Journal:  J Bras Nefrol       Date:  2021 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.